covid 19 News and Research

RSS

Could monitoring headaches after COVID-19 vaccination help identify rare cases of cerebral venous thrombosis?

Researchers from the Akershus University Hospital in Norway investigated 77 cases of CVT in vaccinated subjects to identify risks and warning signs to better predict these severe side effects.

21 Sep 2021

New cell-free antibody generation platform successfully creates neutralizing antibodies effective against SARS-CoV-2

Researchers from the Broad Institute of MIT and Harvard have created a cell-free nanobody engineering platform that can produce antibodies effectively and quickly.

21 Sep 2021

California’s reboot of troubled Medi-Cal puts pressure on health plans

When Denise Williams' baby boy was 2 months old, she became alarmed by a rattling sound in his lungs and took him to the emergency room. While undergoing treatment, he spiraled into a disabling neurological disorder.

21 Sep 2021

Decline in SARS-CoV-2 neutralizing antibodies and unique cytokine profile in severe COVID-19 patients

A new study has focused on antibody levels and cytokine profiles of COVID-19 patients with mild symptoms, pneumonia, and severe pneumonia.

21 Sep 2021

Neurokinin-1 receptor: a potential drug target for the treatment of COVID-19

An opinion article aims to provide evidence that SP could be the possible factor for initiating the cytokine storm during severe SARS-CoV-2 infection.

21 Sep 2021

Maintenance dialysis patients may need additional shots of COVID-19 vaccines

Researchers in the United States have conducted a study showing that the antibody response to vaccination designed to protect against coronavirus disease 2019 (COVID-19) wanes substantially over time among patients receiving maintenance dialysis.

21 Sep 2021

Count of severe COVID-19 no higher in children during second wave compared to first wave

Researchers in the UK have conducted a study suggesting that severe disease in children and young people admitted to hospital following infection with severe acute respiratory syndrome coronavirus (SARS-CoV-2) is still rare and was no more common during the second wave of infections than the first.

21 Sep 2021

Researchers investigate students' belonging insecurity in a STEM course

As a first-year college student in an introductory chemistry class sits down for their midterm, which might be their first stepping stone toward a career in academia, research or medicine, a thought may swirl through their head alongside valence numbers, molar masses and oxidation states - an anxiety that forms itself into a supposition: "Maybe people like me don't belong in this class."

21 Sep 2021

Dynamics of innate immune responses decide COVID-19 severity in genetically diverse mice

In a recently published article on the bioRxiv* preprint server, scientists from the USA and UK have described the significance of early inflammatory signaling pathways in determining the severity of coronavirus disease 2019 (COVID-19).

21 Sep 2021

Changes in fibrin clot structure contributes to thrombosis risk in severe COVID-19

Researchers from Europe recently demonstrated altered levels of factor XII (FXII) and its activation products in 2 independent cohorts of critically ill patients with COVID-19 compared to patients suffering from severe acute respiratory distress syndrome caused by the influenza virus (acute respiratory distress syndrome (ARDS)-influenza).

21 Sep 2021

COVID-19 vaccine effectiveness against SARS-CoV-2 variants

A commentary published in the journal Cell summarizes international data on vaccine effectiveness against new severe acute respiratory coronavirus 2 (SARS-CoV-2) variants. Evidence shows that the currently approved vaccines continue to be effective in preventing severe and symptomatic illness — even with the widely circulating Delta variant.

21 Sep 2021

Study analyzes the impact of kindness on university-aged students

A small act of kindness can go a long way, especially say UBC Okanagan researchers, towards bolstering student health and wellness.

21 Sep 2021

Dutch study shows COVID vaccines 97% effective in preventing ICU admission

Vaccinations help keep people out of the hospital, according to a new preprint medRxiv* study from researchers at the University of Amsterdam and the National Institute for Public Health and the Environment (RIVM) in the Netherlands.

21 Sep 2021

Scientists hypothesize SARS-CoV-2 cryptically circulating among humans before the current outbreak

As nations begin to recover, researchers from the National Taiwan University and Academia Sinica in Taipei have been looking to identify the changes the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) underwent over the course of the pandemic in order to better understand why the disease showed such virulence.

20 Sep 2021

International organizations, vaccine manufacturers discuss strategies to improve access to COVID-19 vaccines

The heads of the International Monetary Fund, World Bank Group, World Health Organization and World Trade Organization met with the CEOs of leading vaccine manufacturing companies to discuss strategies to improve the access to COVID-19 vaccines, especially in low- and lower middle-income countries and in Africa.

20 Sep 2021

Researchers identify prediction markers which can be used to define COVID-19 severity

An estimated 14−17% of hospitalized COVID-19 patients develop a severe form of the disease, requiring oxygen support and admission to the intensive care unit.

20 Sep 2021

New evidence confirms the efficacy of COVID-19 vaccination in cancer patients

The long-awaited confirmation of the efficacy of COVID-19 vaccination in patients with cancer has arrived, on time to be disseminated to a global audience at the annual congress of the European Society for Medical Oncology (ESMO Congress 2021), the leading professional society for medical oncology.

20 Sep 2021

covid 19 News and Research

Could monitoring headaches after COVID-19 vaccination help identify rare cases of cerebral venous thrombosis?

New cell-free antibody generation platform successfully creates neutralizing antibodies effective against SARS-CoV-2

California’s reboot of troubled Medi-Cal puts pressure on health plans

Decline in SARS-CoV-2 neutralizing antibodies and unique cytokine profile in severe COVID-19 patients

Neurokinin-1 receptor: a potential drug target for the treatment of COVID-19

Maintenance dialysis patients may need additional shots of COVID-19 vaccines

Count of severe COVID-19 no higher in children during second wave compared to first wave

Researchers investigate students' belonging insecurity in a STEM course

Dynamics of innate immune responses decide COVID-19 severity in genetically diverse mice

Changes in fibrin clot structure contributes to thrombosis risk in severe COVID-19

COVID-19 vaccine effectiveness against SARS-CoV-2 variants

Study analyzes the impact of kindness on university-aged students

Dutch study shows COVID vaccines 97% effective in preventing ICU admission

Scientists hypothesize SARS-CoV-2 cryptically circulating among humans before the current outbreak

International organizations, vaccine manufacturers discuss strategies to improve access to COVID-19 vaccines

Researchers identify prediction markers which can be used to define COVID-19 severity

New evidence confirms the efficacy of COVID-19 vaccination in cancer patients

A novel FACS-based approach for SARS-CoV-2 serology

Role of extracellular vesicles embedded with engineered ACE2 in the neutralization of the SARS-CoV-2 pseudovirus

Failures and findings from randomized clinical trials in COVID-19 convalescent plasma

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News